Endo Health Solutions agreed to pay about $105 million to acquire NuPathe and its lead product Zecuity, the only FDA-approved prescription patch for migraine. The acquisition could be finalized early next year, and Endo plans to commercialize the migraine patch in the first half of 2014.

Full Story:

Related Summaries